References:
1. American Society of Addiction Medicine. (2020). Alcohol Withdrawal Management.
https://www.asam.org/docs/default-source/quality-science/the_asam_clinical_practice_guideline_on_alcohol-1.pdf?sfvrsn=ba255c2_2
2. Rosenson J, Clements C, Simon B, Vieaux J, Graffman S, Vahidnia F, Cisse B, Lam J, Alter H. Phenobarbital for acute alcohol withdrawal:
a prospective randomized double-blind placebo-controlled study. J Emerg Med. 2013 Mar;44(3):592-598
3. Parthvi R, Agne P. Update on Phenobarbital for Alcohol Withdrawal Syndrome in Intensive Care. J Clin Intensive Care Med. 2019; 4:
036-039
4. Hughes D. Benzodiazepine-refractory alcohol withdrawal. Clinical, Critical Care, Toxicology. 2016
5. Flannery AH, Adkins DA, Cook AM et al. Unpeeling the evidence for the banana bag: evidence-based recommendations for the
management of alcohol-associated vitamin and electrolyte deficiencies in the ICU. Crit Care Med. 2016; 44: 1545-1552
6. Rayner AG, Weinert CR, Peng H, Jepsen S, Broccard AF. Dexmedetomidine as an adjunct treatment for severe alcohol withdrawal in the
ICU. Ann Intensive Care. 2020; 2:12
7. Luminal (phenobarbital) [package insert]. Eatontown, NJ:West-Ward Pharmaceuticals; 2017
Posted 11/8/15 (A Bernard/S Priest); Revised 9/26/24 (A Bernard); Revised 4-18-26 (Bernard/Congleton/Reynolds/Warriner)
